WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Shares Gap Down – Here’s What Happened
by Tristan Rich · The Markets DailyWuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report)’s share price gapped down prior to trading on Thursday. The stock had previously closed at $12.78, but opened at $11.70. WuXi Biologics (Cayman) shares last traded at $11.52, with a volume of 2,889 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, Zacks Research upgraded WuXi Biologics (Cayman) to a “hold” rating in a research note on Friday, August 28th. One equities research analyst has rated the stock with a Hold rating. According to data from MarketBeat, the stock currently has an average rating of “Hold”.
Get Our Latest Stock Report on WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Stock Down 8.9%
The company’s 50 day moving average is $12.95 and its 200 day moving average is $10.38.
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Inc is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company works with pharmaceutical and biotechnology companies to support the discovery, development and commercial manufacturing of therapies, helping customers advance drug candidates from early research through clinical and commercial production.
Its capabilities include antibody and recombinant protein development, cell-line development, process development, clinical trial material production and large-scale biomanufacturing.
Featured Articles
- Five stocks we like better than WuXi Biologics (Cayman)
- Flywire’s Rapid Growth Faces a Q3 Test—Is Its Stock Already Too Expensive?
- Cologuard Is Working—So Why Isn’t Abbott Stock?
- Micron’s Taiwan Strike: A High-Stakes Fight Over AI Profits
- Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story